This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
141 |
4. Check minimum number of eventsNone |
141 |
5. Include endpointsNone |
141 |
6. Filter based on genotype QC (FinnGen only) |
125 |
Control definitions (FinnGen only)
- Control exclude
- K11_ENERCOLNONINF
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K52
- Name in latin
- Gastroenteritis toxica
Similar endpoints
↥List of similar endpoints to
Toxic colitis
based on the number of shared cases.
Similar with more cases:
- Other noninfective gastroenteritis and colitis
- Noninfective enteritis and colitis
- Gastrointestinal diseases
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 125 | 70 | 55 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 60.64 | 54.32 | 68.69 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 129
- Matched controls
- 1290
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K52.1
ICD-10 Finland
Toxic gastroenteritis and colitis
+∞
186.3
129
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
24.8
23
*
A07EC02
ATC
mesalazine; oral, rectal
67.5
24.1
27
5
UJF32
NOMESCO Finland
Coloscopy
5.8
22.0
64
188
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
58.4
21.0
24
5
A03FA01
ATC
metoclopramide; systemic, rectal
5.5
20.5
63
192
A04AA02
ATC
granisetron; systemic, transdermal
8.2
19.7
30
46
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
8.4
19.1
28
41
JN4BD
NOMESCO Finland
Extensive body CT
6.3
17.6
36
75
H02AB02
ATC
dexamethasone; systemic
5.5
16.4
40
98
K51.5
ICD-10 Finland
Left sided colitis
+∞
16.0
15
*
JN4AD
NOMESCO Finland
Body CT examination
5.5
15.6
37
88
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.8
15.0
23
35
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
+∞
14.9
14
*
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
14.9
14
*
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
+∞
14.9
14
*
130
Kela drug reimbursment
Malignant tumour
5.6
14.8
33
74
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.3
13.7
33
79
R11
ICD-10 Finland
Nausea and vomiting
5.7
13.6
29
62
ZX120
NOMESCO Finland
Intravenous
5.7
13.6
29
62
UJF30
NOMESCO Finland
Ileoscopy through colon
6.0
13.1
26
52
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.9
13.0
58
222
A04AA01
ATC
ondansetron; systemic, rectal
5.7
12.3
26
55
Z51.5
ICD-10 Finland
Palliative care
5.3
12.1
28
64
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.0
11.6
43
143
N02AA05
ATC
oxycodone; systemic
3.9
11.5
47
167
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
11.2
33
92
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.4
11.2
23
29
A07EA06
ATC
budesonide; oral, local oral
24.0
11.0
15
7
L01BC06
ATC
capecitabine; oral
9.6
10.9
22
27
H02AB06
ATC
prednisolone; systemic
3.4
10.2
85
465
A07EA02
ATC
hydrocortisone; rectal
43.8
10.2
12
*
A02BC02
ATC
pantoprazole; systemic
4.2
9.4
107
696
L04AX01
ATC
azathioprine; systemic
17.2
9.3
14
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
8.7
29
88
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.1
8.6
19
27
P01AB01
ATC
metronidazole; oral, rectal
3.0
8.5
68
352
N02AX02
ATC
tramadol; systemic, rectal
2.9
8.1
71
384
WZC00
NOMESCO Finland
Treatment plan or consultation
2.9
8.0
66
345
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.9
8.0
19
44
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
7.9
41
165
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.7
7.6
17
25
K51
ICD-10 Finland
Ulcerative colitis
+∞
7.4
7
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
7.1
23
68
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
7.0
76
449
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.2
6.9
20
54
B01AB05
ATC
enoxaparin; parenteral
2.6
6.5
53
270
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
7.7
6.4
14
20
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
19.2
6.4
9
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
6.1
32
128
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.8
6.1
39
174
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.0
6.1
14
22
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
51
60
13.40
43.18
2.1
1.5
—
—
—
0
0
92
489
4.07
12.43
13.2
4.8
33.26
36.15
g/l
3.58
92
470
23
27
10.12
11.64
1.3
1.1
—
—
—
0
0
53
204
3.71
11.55
8.8
3.0
0.79
0.82
mmol/l
1.37
53
193
106
652
4.51
10.90
26.3
10.3
4.20
4.04
e9/l
0.33
98
568
98
608
3.55
9.12
21.6
6.7
10.53
11.36
umol/l
0.41
98
581
47
201
3.11
8.24
2.6
1.8
—
—
—
0
0
19
31
7.00
7.91
2.2
1.3
211.00
293.02
ug/g
0.90
14
13
16
22
8.14
7.46
1.8
1.4
—
—
—
0
0
88
555
2.84
7.15
13.4
7.3
1.19
1.21
mmol/l
2.31
81
488
21
59
4.06
6.93
1.7
1.3
—
—
—
0
0
39
164
2.98
6.90
9.9
6.5
104.46
104.54
mmol/l
0.04
39
164
36
146
3.03
6.78
2.7
1.7
—
—
—
0
0
37
153
2.99
6.73
9.6
6.8
1.03
1.05
mmol/l
0.14
37
138
71
412
2.61
6.66
4.5
3.2
—
—
—
0
0
81
502
2.65
6.61
12.0
6.2
1.19
1.22
mmol/l
2.38
81
471
36
152
2.90
6.27
2.6
1.6
—
—
—
0
0
55
289
2.57
6.25
2.6
2.1
2.88
2.71
mg/l
0.24
50
256
31
121
3.06
6.20
5.5
4.1
5.80
5.82
kpa
0.04
31
116
20
64
3.51
5.46
1.8
1.6
—
—
—
0
0
29
125
2.70
4.78
4.1
2.2
38.72
27.97
u/l
0.96
29
100
42
217
2.39
4.75
6.0
3.7
42.00
243.38
ng/l
0.85
32
164
38
192
2.39
4.49
4.4
2.8
2.23
2.18
e6/l
0.02
26
94
8
9
9.38
4.34
2.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
25
5.18
4.31
3.8
2.3
0.25
0.42
iu/ml
—
5
12
19
71
2.97
4.03
7.7
5.4
23.64
25.31
mmol/l
0.84
19
71
75
517
2.08
3.97
5.0
2.7
—
—
estimate
—
0
0
24
103
2.63
3.96
4.2
3.0
3.73
4.56
kpa
2.61
24
98
8
12
7.02
3.73
3.7
3.8
3.09
3.67
nmol/l
—
8
12
11
25
4.71
3.72
3.1
1.4
—
—
—
0
0
55
348
2.01
3.59
5.1
3.1
0.83
0.43
e6/l
0.30
49
254
12
32
4.03
3.49
3.3
1.4
—
—
—
0
0
12
33
3.90
3.39
3.3
1.4
—
—
—
0
0
54
347
1.96
3.33
3.9
3.8
0.00
0.00
estimate
-0.00
21
117
44
265
2.00
3.25
3.4
4.0
1.02
1.02
kg/l
0.02
31
163
82
611
1.94
3.20
5.3
4.1
0.00
0.00
estimate
-0.00
23
128
17
69
2.69
3.11
3.8
2.8
0.70
0.66
%
0.33
17
69
17
69
2.69
3.11
3.8
2.8
1.14
1.21
%
0.17
17
69
81
605
1.91
3.09
5.2
4.1
0.00
0.00
estimate
-0.00
22
128
15
57
2.85
3.09
1.1
1.3
—
—
—
0
0
6
8
7.79
3.09
1.7
2.3
79.33
106.38
%
—
6
8
9
21
4.52
3.05
3.8
1.3
—
—
—
0
0
11
32
3.66
2.98
1.2
1.1
—
—
—
0
0
11
32
3.66
2.98
1.2
1.1
—
—
—
0
0
11
32
3.66
2.98
1.3
1.9
—
—
—
0
0
82
622
1.87
2.91
5.3
4.1
0.00
2.40
estimate
0.50
21
125
7
13
5.62
2.91
1.4
1.5
—
—
—
0
0
7
13
5.62
2.91
2.7
1.5
—
—
—
0
0
37
219
1.97
2.83
4.9
2.7
0.62
0.93
e6/l
0.60
25
119
7
15
4.87
2.63
3.3
1.3
—
—
—
0
0
5
7
7.37
2.57
2.6
2.3
—
—
—
0
0
5
7
7.37
2.57
4.4
4.6
75.20
115.14
nmol/l
—
5
7
9
26
3.64
2.53
2.9
1.4
—
—
—
0
0
7
16
4.56
2.51
1.3
1.4
305.43
246.67
u/ml
—
7
6
5
8
6.44
2.39
2.6
2.1
—
—
—
0
0
5
8
6.44
2.39
1.0
1.0
—
—
—
0
0
5
8
6.44
2.39
2.6
2.1
—
—
—
0
0
5
8
6.44
2.39
2.6
2.1
—
—
—
0
0
41
264
1.81
2.39
4.3
2.2
—
—
—
0
0
8
23
3.64
2.31
2.9
1.2
—
—
—
0
0
7
18
4.05
2.28
1.3
1.3
—
—
—
0
0
11
41
2.84
2.27
3.1
2.3
—
—
—
0
0
5
9
5.73
2.23
2.6
2.0
—
—
—
0
0
5
9
5.73
2.23
2.6
2.0
—
—
—
0
0
24
132
2.01
2.23
1.9
1.7
1.65
1.47
%
0.59
19
115
6
14
4.44
2.17
1.8
1.2
—
—
—
0
0
63
469
1.67
2.15
4.4
3.9
0.00
0.00
estimate
-0.00
20
113
9
31
3.04
2.12
2.9
1.4
—
—
—
0
0
9
31
3.04
2.12
2.9
1.9
251.78
182.48
%
—
9
31
18
91
2.14
2.07
2.3
2.4
0.64
1.16
e6/l
0.21
18
85
6
15
4.14
2.06
4.2
1.3
—
—
—
0
0
119
1071
2.43
2.02
45.5
15.6
25.68
22.81
mg/l
0.52
113
882
11
45
2.58
1.99
2.0
1.8
12.42
9.63
g/l
1.07
11
40
5
11
4.68
1.96
1.4
1.3
—
—
—
0
0
19
101
2.03
1.93
4.3
3.3
84.00
60.98
ml/min/173m2
—
6
45
11
46
2.52
1.91
2.2
1.8
2.32
0.37
g/l
0.59
11
41
7
22
3.30
1.91
3.3
1.3
—
—
—
0
0
7
22
3.30
1.91
1.9
2.0
—
—
—
0
0
5
12
4.29
1.84
3.4
1.6
—
—
—
0
0
5
13
3.95
1.73
3.2
1.2
21.08
13.54
ug/l
—
5
13
5
13
3.95
1.73
4.0
2.2
—
—
—
0
0
20
113
1.91
1.72
12.1
7.2
—
—
—
0
0
5
14
3.67
1.63
2.8
3.7
27.20
123.98
u/ml
—
5
14
97
837
1.64
1.62
6.2
4.2
14.87
12.36
mm/h
0.80
92
772
7
26
2.79
1.60
2.1
1.3
—
—
—
0
0
7
26
2.79
1.60
3.3
1.4
—
—
—
0
0
64
506
1.53
1.56
2.3
2.0
94.56
98.32
pmol/l
0.30
41
263
9
37
2.54
1.51
2.9
1.7
86.67
92.95
%
—
9
37
104
920
1.67
1.50
51.8
19.7
14.49
13.60
%
7.14
104
915
6
22
2.81
1.45
1.2
1.3
—
—
—
0
0
6
22
2.81
1.45
3.0
3.4
14.33
47.84
u/ml
—
6
22
9
42
2.23
1.37
2.2
1.9
0.00
0.00
g/l
—
9
36
57
451
1.47
1.33
4.8
3.9
23.90
41.34
ng/l
1.04
45
324
45
340
1.50
1.31
4.1
3.3
1993.41
1119.68
ng/l
0.35
40
288
34
243
1.54
1.28
1.9
1.7
2.48
1.56
mg/l
0.50
28
200
8
37
2.24
1.24
2.6
2.1
—
—
—
0
0
8
37
2.24
1.24
1.9
1.9
—
—
—
0
0
118
1095
1.91
1.24
45.1
18.1
138.91
139.86
mmol/l
3.46
118
1076
118
1096
1.90
1.22
45.7
18.3
3.96
3.97
mmol/l
0.09
118
1074
5
20
2.56
1.16
2.8
3.0
—
—
—
0
0
12
66
1.90
1.13
3.8
3.5
4.36
4.46
pmol/l
0.21
12
60
7
32
2.25
1.10
1.4
1.4
—
79.70
—
0
5
7
34
2.12
1.04
1.3
1.2
—
—
—
0
0
5
22
2.32
1.04
3.6
2.5
12.36
16.50
%
—
5
22
7
36
2.00
0.98
1.0
1.4
—
—
—
0
0
120
1138
1.78
0.96
51.9
20.2
80.77
78.80
umol/l
0.15
120
1129
42
342
1.34
0.77
4.2
3.5
0.05
0.24
estimate
0.35
19
104
108
1010
1.43
0.73
6.5
5.4
1.91
1.90
mu/l
0.04
101
935
27
207
1.38
0.71
1.4
1.6
—
—
—
0
0
9
58
1.59
0.71
1.6
2.3
—
—
—
0
0
14
198
0.67
0.66
1.4
1.4
1.38
7.81
u/ml
—
6
76
100
1061
0.74
0.64
5.0
5.2
1.34
1.47
mmol/l
2.57
88
982
95
1009
0.78
0.55
4.6
4.4
1.75
1.29
mmol/l
0.75
84
927
6
38
1.61
0.55
1.7
1.3
—
—
—
0
0
44
380
1.24
0.50
3.9
4.1
4.37
10.18
mg/mmol
1.62
30
246
10
70
1.46
0.43
1.6
2.3
—
—
—
0
0
102
1065
0.80
0.41
5.0
5.3
4.46
4.63
mmol/l
0.48
90
994
104
1083
0.80
0.40
5.6
6.0
2.48
2.71
mmol/l
1.77
92
1006
120
1167
1.41
0.37
63.5
24.1
127.37
135.23
g/l
6.58
120
1160
120
1166
1.42
0.37
62.2
23.9
91.46
91.13
fl
0.33
120
1160
120
1166
1.42
0.37
63.5
24.4
38.49
40.41
%
5.21
120
1158
108
1041
1.23
0.32
40.1
15.0
82.38
80.32
ml/min/173m2
0.44
99
974
30
263
1.18
0.29
1.5
1.3
7.84
0.84
u/ml
—
10
66
72
676
1.15
0.29
3.2
3.0
—
—
—
0
0
5
38
1.33
0.23
1.0
1.2
1.04
0.91
g/l
—
5
38
5
38
1.33
0.23
1.0
1.2
1.71
1.60
g/l
—
5
38
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
4.20
—
0
5
0
12
0.00
0.21
0.0
2.5
—
28.00
—
0
6
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
43.86
—
0
7
0
13
0.00
0.21
0.0
1.0
—
449.75
—
0
8
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
51
1.18
0.19
1.5
1.5
31.15
23.21
iu/l
—
6
42
30
327
0.89
0.17
5.1
4.8
19.93
22.20
%
0.51
16
157
19
168
1.15
0.17
1.4
1.5
—
—
—
0
0
11
93
1.20
0.15
9.5
4.0
1.22
1.22
mmol/l
0.17
11
81
14
122
1.17
0.14
6.8
2.9
—
—
—
0
0
22
240
0.90
0.12
2.7
3.1
0.83
0.76
ug/l
0.13
15
159
12
109
1.11
0.06
1.9
1.4
—
—
—
0
0
11
121
0.90
0.06
2.5
2.3
—
—
—
0
0
105
1044
1.03
0.00
5.6
5.1
6.34
5.93
mmol/l
1.80
96
965
11
111
0.99
0.00
2.2
2.2
—
—
—
0
0
10
97
1.03
0.00
1.6
2.2
6.38
13.57
nmol/l
—
10
91
0
5
0.00
-0.00
0.0
1.2
—
7.86
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
11.00
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
64.42
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
13.26
—
0
7
0
5
0.00
-0.00
0.0
1.8
—
187.00
—
0
5
0
6
0.00
-0.00
0.0
2.8
—
13.28
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: COLITTOX – Toxic colitis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).